CAR-T Cell Therapy for Multiple Myeloma - Michaela Liedtke, MD | MCRT Webcast Apr 24, 2021

[@carloskano588]

How does one qualify for a treatment like this? Is this already being used for multiple myeloma patients?

[@jennyahlstrom3609]

Carlos. There is one fda approved car t therapy called Abecma by BMS approved for relapsed/refractory myeloma patients who have had more than 4 prior lines of therapy. The next one that is likely for approval is the Janssen CAR T which may get approved in November but is currently still in clinical trials.

[@rhettsmedia]

I would like to see the paper for this and I’d like to see the speaker not be so nervous and I’d like to see the pathways a little bit better about what kills what I’m a recently diagnosed person and I would like to know

[@claudeabrown7746]

Please Help me my son needs this!

[@HealthTreeForMyeloma]

Does your son have a multiple myeloma specialist?

[@claudeabrown7746]

@@HealthTreeForMyeloma no

[@claudeabrown7746]

No he doesn't

[@HealthTreeForMyeloma]

We have a specialized team that can help with all your multiple myeloma questions, you can have access to that free service by contacting us here: [e-mail] As a friendly reminder, keep in mind that they cannot provide medical advice, but we can guide you on what you need.